Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Efficacy and safety of short (≤6 months) versus prolonged (>6 months) dual antiplatelet therapy following percutaneous coronary intervention: a systematic review and meta-analysis

The optimal duration of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) remains uncertain, as therapy must balance ischemic protection against bleeding risk. While prolonged DAPT may enhance antithrombotic efficacy, shorter regimens have been proposed to improve safety. To c...

A. Gasca, N. Nelson, A. Beltran et al. · 0 citations
Review Open access Oct 2026

Standard versus extended dual antiplatelet therapy after pci in acute coronary syndrome: a systematic review and meta-analysis

The absence of benefit was confirmed both during overall follow-up and in landmark 12-month analyses, with a reduction observed only in repeat revascularisation, a softer endpoint, and findings support an individualised approach to DAPT duration rather than routine prolongation beyond one year.

A. Gasca, N. Murillo, S. Cordoba et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.